journal article·2022-06

Pulsed Microwave‐Induced Thermoacoustic Shockwave for Precise Glioblastoma Therapy with the Skin and Skull Intact

Wenjing Li, Shanxiang Zhang, Da Xing, Huan Qin

Small· Volume 18· Issue 25
Publisher page

Abstract

Abstract Glioblastoma has a dismal prognosis and is a critical and urgent health issue that requires aggressive research and determined clinical efforts. Due to its diffuse and infiltrative growth in the brain parenchyma, complete neurosurgical resection is rarely possible. Here, pulsed microwave‐induced thermoacoustic (MTA) therapy is proposed as a potential alternative modality to precisely and effectively eradicate in vivo orthotopic glioblastoma. A nanoparticle composed of polar amino acids and adenosine‐based agonists is constructed with high microwave absorbance and selective penetration of the blood‐brain barrier (BBB) at the tumor site. This nanoparticle can activate the adenosine receptor on the BBB to allow self‐passage and tumor accumulation. The nanoparticle converts absorbed microwaves into ultrasonic shockwaves via the thermoacoustic cavitation effect. The ultrasonic shockwave can mechanically destroy tumor cells within a short range with minimal damage to adjacent normal brain tissue due to the rapid decay of the ultrasonic shockwave intensity. The deep tissue penetration characteristics of the microwave and the rapid decay of the ultrasonic shockwave make MTA therapy a promising glioblastoma cure including intact skin and skull.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Ultrasound and Hyperthermia Applications · Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science College of Biophotonics South China Normal University Guangzhou 510631 P. R. China

Guangdong Provincial Key Laboratory of Laser Life Science College of Biophotonics South China Normal University Guangzhou 510631 China

Guangzhou Key Lab of Spectral Analysis and Functional Probes College of Biophotonics South China Normal University Guangzhou 510631 China

Funding

National Natural Science Foundation of China · Science and Technology Planning Project of Guangdong Province · Scientific and Technological Planning Project of Guangzhou City

References (56)

Show source-provided references
1. 10.1073/pnas.97.12.624210.1073/pnas.97.12.6242 ↗
2. 10.1001/jama.2013.28031910.1001/jama.2013.280319 ↗
3. 10.1158/0008-5472.CAN-10-455710.1158/0008-5472.CAN-10-4557 ↗
4. 10.1016/S1470-2045(06)70665-910.1016/S1470-2045(06)70665-9 ↗
5. 10.1038/nrc274810.1038/nrc2748 ↗
6. 10.1200/JCO.2005.04.530210.1200/JCO.2005.04.5302 ↗
7. 10.1021/nn506248s10.1021/nn506248s ↗
8. 10.1038/nrc159010.1038/nrc1590 ↗
9. 10.1038/sj.cdd.440187210.1038/sj.cdd.4401872 ↗
10. 10.1146/annurev-pathol-011110-13032410.1146/annurev-pathol-011110-130324 ↗
11. 10.1038/nrc107010.1038/nrc1070 ↗
12. 10.1021/jacs.0c1285110.1021/jacs.0c12851 ↗
13. 10.1002/adfm.20190911710.1002/adfm.201909117 ↗
14. 10.1021/cr500419810.1021/cr5004198 ↗
15. 10.1021/ja508679h10.1021/ja508679h ↗
16. 10.1021/acsnano.7b0322610.1021/acsnano.7b03226 ↗
17. 10.1002/adma.20180259110.1002/adma.201802591 ↗
18. 10.1021/nn305864210.1021/nn3058642 ↗
19. 10.1021/acsnano.5b0002110.1021/acsnano.5b00021 ↗
20. 10.1002/adfm.20190482710.1002/adfm.201904827 ↗
21. 10.2217/nnm.12.12310.2217/nnm.12.123 ↗
22. 10.1002/smll.20110189210.1002/smll.201101892 ↗
23. 10.1364/BOE.3.00043510.1364/BOE.3.000435 ↗
24. 10.1073/pnas.101577110810.1073/pnas.1015771108 ↗
25. 10.1103/PhysRevLett.84.132810.1103/PhysRevLett.84.1328 ↗
26. 10.1016/j.ctrv.2012.07.00410.1016/j.ctrv.2012.07.004 ↗
27. 10.1002/smll.20140339510.1002/smll.201403395 ↗
28. 10.1021/acsnano.6b0474910.1021/acsnano.6b04749 ↗
29. 10.1063/1.497520410.1063/1.4975204 ↗
30. 10.1007/s12274-020-3277-810.1007/s12274-020-3277-8 ↗
31. 10.7150/thno.1784610.7150/thno.17846 ↗
32. 10.1039/C8NR08498J10.1039/C8NR08498J ↗
33. 10.1021/acs.nanolett.8b0472310.1021/acs.nanolett.8b04723 ↗
34. 10.1021/nn500337510.1021/nn5003375 ↗
35. 10.1016/j.mattod.2021.08.01310.1016/j.mattod.2021.08.013 ↗
36. 10.1002/smll.20130167310.1002/smll.201301673 ↗
37. Daneman R. · Biol · 2015 · 7
38. 10.1093/neuonc/2.1.4510.1093/neuonc/2.1.45 ↗
39. 10.1177/0271678X1663099110.1177/0271678X16630991 ↗
40. 10.1172/JCI7620710.1172/JCI76207 ↗
41. 10.1007/s12035-014-8879-210.1007/s12035-014-8879-2 ↗
42. 10.1186/s12987-015-0017-710.1186/s12987-015-0017-7 ↗
43. 10.1523/JNEUROSCI.3337-11.201110.1523/JNEUROSCI.3337-11.2011 ↗
44. 10.1126/science.751275110.1126/science.7512751 ↗
45. 10.1002/ijc.1026510.1002/ijc.10265 ↗
46. 10.1097/00006123-200101000-0002610.1097/00006123-200101000-00026 ↗
47. 10.1103/PhysRevApplied.10.02404410.1103/PhysRevApplied.10.024044 ↗
48. 10.1088/0031-9155/52/10/00110.1088/0031-9155/52/10/001 ↗
49. 10.1103/PhysRevLett.109.21810110.1103/PhysRevLett.109.218101 ↗
50. 10.1021/mp300273310.1021/mp3002733 ↗
51. 10.1021/nn402662d10.1021/nn402662d ↗
52. 10.1002/adfm.20180002510.1002/adfm.201800025 ↗
53. 10.1016/j.ijpharm.2005.03.03110.1016/j.ijpharm.2005.03.031 ↗
54. 10.1016/j.ijpharm.2013.10.00310.1016/j.ijpharm.2013.10.003 ↗
55. 10.1038/nprot.2010.7610.1038/nprot.2010.76 ↗
56. 10.1016/S0928-0987(00)00123-810.1016/S0928-0987(00)00123-8 ↗